Abstract
The aim of this study was to evaluate the effect of ganciclovir on human herpesvirus-6 (HHV)-6. Forty allogeneic stem cell transplant recipients were prospectively studied by repeated sampling of the saliva. The saliva samples were assayed for HHV-6 by quantitative polymerase chain reaction. HHV-6 was detected in 33 patients. Ganciclovir was given as preemptive therapy for cytomegalovirus infection during 15 episodes that were compared to 18 episodes without any concomitant antiviral therapy. The mean HHV-6 load decreased 0.49 (s.e. 0.31) log10/week in patients receiving ganciclovir whereas it increased 0.15 (s.e. 0.17) log10/week in episodes without antiviral therapy (P=0.04). We conclude that ganciclovir can decrease the HHV-6 viral load in saliva.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bosi A, Zazzi M, Amantini A, Cellerini M, Vannucchi AM, De Milito A et al. Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant. Bone Marrow Transplant 1998; 22: 285–288.
Rieux C, Gautheret-Dejean A, Challine-Lehmann D, Kirch C, Agut H, Vernant JP . Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation. Transplantation 1998; 65: 1408–1411.
Zerr DM, Gooley TA, Yeung L, Huang ML, Carpenter P, Wade JC et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 33: 763–771.
Mookerjee BP, Vogelsang G . Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplantation 1997; 20: 905–906.
Drobyski WR, Knox KK, Majewski D, Carrigan DR . Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–1360.
Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC . Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991; 338: 147–149.
Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167: 735–739.
Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111: 774–781.
Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P . Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28: 562–568.
Carrigan DR, Knox KK . Bone marrow suppression by human herpesvirus-6: comparison of the A and B variants of the virus (letter; comment). Blood 1995; 86: 835–836.
Le Blanc K, Remberger M, Uzunel M, Mattsson J, Barkholt L, Ringden O . A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation 2004; 78: 1014–1020.
Enbom M, Strand A, Falk KI, Linde A . Detection of Epstein–Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction. Sex Transm Dis 2001; 28: 300–306.
Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P . Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615–3620.
Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99: 1159–1164.
Long MC, Bidanset DJ, Williams SL, Kushner NL, Kern ER . Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry. Antiviral Res 2003; 58: 149–157.
De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J . Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001; 11: 381–395.
Zerr DM, Gupta D, Huang ML, Carter R, Corey L . Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 309–317.
Tokimasa S, Hara J, Osugi Y, Ohta H, Matsuda Y, Fujisaki H et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29: 595–598.
Acknowledgements
We thank Kirsti Niemelä, Mari Svensson and Marie Abrahamsson for collecting the samples. The study was supported by a grant from the Swedish Children's Cancer Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ljungman, P., Dahl, H., Xu, YH. et al. Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients. Bone Marrow Transplant 39, 497–499 (2007). https://doi.org/10.1038/sj.bmt.1705617
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705617
Keywords
This article is cited by
-
Clinical significance of cancer-related fatigue in multiple myeloma patients
International Journal of Hematology (2018)
-
Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovir
Bone Marrow Transplantation (2015)